×







We sell 100% Genuine & New Books only!

Biologics for the Treatment of Rheumatoid Arthritis 1st Editon 2016 Softbound at Meripustak

Biologics for the Treatment of Rheumatoid Arthritis 1st Editon 2016 Softbound by Ronald van Vollenhoven, Springer

Books from same Author: Ronald van Vollenhoven

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Price: ₹ 6472.00/- [ 15.00% off ]

    Seller Price: ₹ 5501.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)Ronald van Vollenhoven
    PublisherSpringer
    Edition1st Editon
    ISBN9783319131078
    Pages132
    BindingSoftbound
    LanguageEnglish
    Publish YearFebruary 2016

    Description

    Springer Biologics for the Treatment of Rheumatoid Arthritis 1st Editon 2016 Softbound by Ronald van Vollenhoven

    This book provides a comprehensive overview of the available biologic therapies whilst comparing them to standard disease modifying anti-rheumatic drugs, and discusses how best to determine which therapy is most appropriate for an individual patient in the framework of current guidelines. Biologics for the Treatment of Rheumatoid Arthritis is an up-to-date and concise practical guide to the latest therapeutic developments in this field. This book is an invaluable source of topical information for all rheumatologists and health care professionals treating patients with rheumatoid arthritis. Disease overview.- General treatment aspects.- Overview of biologic therapies.- Cytokine inhibitors.- B-cell directed therapy.- T-cell directed therapy.- Novel biologics and small molecules with biologic-like effects.- Strategies for the optimal use of biologic agents in rheumatoid arthritis.- Considerations for special patient populations.- Conclusions and future outlook



    Book Successfully Added To Your Cart